Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | NR3C2 | P08235 | 6/20 | 1.00 |
| ▸ | HSD11B2 | P80365 | 5/20 | 1.00 |
| ▸ | HSD11B1 | P28845 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.79 |
| ▸ | LMNA | P02545 | 5/20 | 0.79 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.79 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.79 |
| ▸ | TSHR | P16473 | 3/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.79 |
| ▸ | SHBG | P04278 | 3/20 | 0.79 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.79 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.79 |
| ▸ | SLC22A3 | O75751 | 2/20 | 0.79 |
| ▸ | THPO | P40225 | 2/20 | 0.79 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.79 |
| ▸ | BLM | P54132 | 1/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 11Beta-Hydroxyprogesterone SCHEMBL18927076 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL572275 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL14217113 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL23131395 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL656895 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL24900301 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL19327159 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL13753022 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL4895684 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 | |
| 11Beta-Hydroxyprogesterone SCHEMBL14039977 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR3C2HSD11B2HSD11B1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230298758-A1 | Systems and Methods for Evaluating Gestational Progress and Applications Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-09-21 | — | — | US | claimed |
| CN-114836387-B | 11-alpha hydroxyprogesterone monoclonal antibody hybridoma cell strain and application thereof | 江南大学 | 2023-08-04 | — | — | CN | claimed |
| CN-115607510-A | High-concentration oleanolic acid nanoemulsion composition and preparation method thereof | 泉州达浔生物科技有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-114836387-A | 11-alpha hydroxyprogesterone monoclonal antibody hybridoma cell strain and application thereof | 江南大学 | 2022-08-02 | — | — | CN | claimed |
| US-11207511-B2 | Methods for treating baldness and promoting hair growth | FOLLICA, INC. (US) | 2021-12-28 | — | — | US | claimed |
| US-20210355157-A1 | NEUROACTIVE STEROIDS AND METHODS OF PREPARATION | DRAWBRIDGE PHARMACEUTICALS PTY LTD (AU) | 2021-11-18 | — | — | US | claimed |
| US-20140079686-A1 | Methods For Treating Baldness And Promoting Hair Growth | FOLLICA, INC. | 2014-03-20 | — | — | US | claimed |
| US-8470602-B2 | Methods and systems for determining the presence or amount of delta 5 steroid compounds in a sample | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2013-06-25 | — | — | US | claimed |
| US-20120270327-A1 | Methods and Systems for Determining the Presence or Amount of Delta 5 Steroid Compounds in a Sample | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2012-10-25 | — | — | US | claimed |
| US-20120156228-A1 | Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair | FOLLICA, INC. (US) | 2012-06-21 | — | — | US | claimed |
| CN-1047620-A | Alteration of hair growth | KASZYNSKI EDWIN G (US) | 1990-12-12 | — | — | CN | claimed |
| US-4885289-A | APPLYING ANTIANDROGEN TO SKIN | GILLETTE COMPANY | 1989-12-05 | — | — | US | claimed |
| CN-85101410-A | Alteration of hair growth | — | 1987-01-10 | — | — | CN | claimed |
| CN-85108498-A | Hair growth modification agent | — | 1986-06-10 | — | — | CN | claimed |
| EP-0016239-B1 | COSMETIC HAIR AND SKIN PREPARATION AND ITS MANUFACTURE | Tamm, Jürgen, Prof. Dr. med. (DE) | 1981-12-30 | — | — | EP | claimed |
| US-4272508-A | TREATMENT WITH 11-2-HYDROXYPROGESTERONE AND ESTERS THEREOF | TAMM JURGEN | 1981-06-09 | — | — | US | claimed |
| US-4230621-A | TRACERS, HYDROXYPHENYLGLUTARIC ACID DERIVATIVES | E. R. SQUIBB & SONS, INC. (US) | 1980-10-28 | — | — | US | claimed |
| US-4215102-A | Cytochemical agents and methods for the detection of steroid hormone receptors in human tissues | LEE SIN H | 1980-07-29 | — | — | US | claimed |
| EP-0003583-A1 | Compositions for cytochemical investigation, their use and method for the detection of steroid hormone receptors in human tissues | Lee, Sin Hang (US) | 1979-08-22 | — | — | EP | claimed |
| US-4115539-A | RADIOIMMUNOASSAY, REACTION PRODUCT WITH ISOCYANATES | UNION CARBIDE CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140079686-A1 | Methods For Treating Baldness And Promoting Hair Growth | AREG, FGF1, NGF | SMN1; SMN2 4725/4885NR3C2 376/4885HSD11B2 266/4885 |
| US-11207511-B2 | Methods for treating baldness and promoting hair growth | AREG, FGF1, NGF | SMN1; SMN2 4725/4885NR3C2 376/4885HSD11B2 266/4885 |
| US-20210355157-A1 | NEUROACTIVE STEROIDS AND METHODS OF PREPARATION | GAP43, CHRNB4, ADRA2C | SMN1; SMN2 405/4885NR3C2 38/4885HSD11B2 27/4885 |
| US-20120156228-A1 | Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair | NGF, HDGF, SHH | SMN1; SMN2 4881/4885NR3C2 2262/4885HSD11B2 644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.